Cargando…
The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition
Curcumin, the active component of turmeric, has been shown to protect against carcinogenesis and prevent tumor development in cancer. In our study, we tested the efficacy of a synthetic curcumin analogue, known as hydrazinocurcumin (HC), in breast cancer cells. The results demonstrated that compared...
Autores principales: | WANG, XIAOFEI, ZHANG, YAN, ZHANG, XIWEN, TIAN, WENXIA, FENG, WENLI, CHEN, TINGMEI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584822/ https://www.ncbi.nlm.nih.gov/pubmed/22179587 http://dx.doi.org/10.3892/ijo.2011.1298 |
Ejemplares similares
-
Hydrazinocurcumin Encapsuled Nanoparticles “Re-Educate” Tumor-Associated Macrophages and Exhibit Anti-Tumor Effects on Breast Cancer Following STAT3 Suppression
por: Zhang, Xiwen, et al.
Publicado: (2013) -
Expression of Concern: Hydrazinocurcumin Encapsuled Nanoparticles "Re-Educate" Tumor-Associated Macrophages and Exhibit Anti-Tumor Effects on Breast Cancer Following STAT3 Suppression
Publicado: (2019) -
New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells
por: Cen, Ling, et al.
Publicado: (2009) -
Hydrazinocurcumin Induces Apoptosis of Hepatocellular Carcinoma Cells Through the p38 MAPK Pathway
por: He, Hongtao, et al.
Publicado: (2020) -
Curcumin analogue BDDD-721 exhibits more potent anticancer effects than curcumin on medulloblastoma by targeting Shh/Gli1 signaling pathway
por: Gong, Weiyi, et al.
Publicado: (2022)